Patents Assigned to Thervance, Inc.
  • Hydrochloride salts of a glycopeptide phosphonate derivative
    Patent number: 8003755
    Abstract: Disclosed are hydrochloride salts of telavancin having a chloride ion content of from about 2.4 wt. % to about 4.8 wt. %. The disclosed salts have improved stability during storage at ambient temperatures compared to other hydrochloride salts. Also disclosed are processes for preparing such salts.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: August 23, 2011
    Assignee: Thervance, Inc.
    Inventors: Jyanwei Liu, Junning Lee